Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.
<h4>Background</h4>Glucosamine and chondroitin are popular non-vitamin dietary supplements used for osteoarthritis. Long-term use is associated with lower incidence of colorectal and lung cancers and with lower mortality; however, the mechanism underlying these observations is unknown. I...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117534&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850191102597922816 |
|---|---|
| author | Sandi L Navarro Emily White Elizabeth D Kantor Yuzheng Zhang Junghyun Rho Xiaoling Song Ginger L Milne Paul D Lampe Johanna W Lampe |
| author_facet | Sandi L Navarro Emily White Elizabeth D Kantor Yuzheng Zhang Junghyun Rho Xiaoling Song Ginger L Milne Paul D Lampe Johanna W Lampe |
| author_sort | Sandi L Navarro |
| collection | DOAJ |
| description | <h4>Background</h4>Glucosamine and chondroitin are popular non-vitamin dietary supplements used for osteoarthritis. Long-term use is associated with lower incidence of colorectal and lung cancers and with lower mortality; however, the mechanism underlying these observations is unknown. In vitro and animal studies show that glucosamine and chondroitin inhibit NF-kB, a central mediator of inflammation, but no definitive trials have been done in healthy humans.<h4>Methods</h4>We conducted a randomized, double-blind, placebo-controlled, cross-over study to assess the effects of glucosamine hydrochloride (1500 mg/d) plus chondroitin sulfate (1200 mg/d) for 28 days compared to placebo in 18 (9 men, 9 women) healthy, overweight (body mass index 25.0-32.5 kg/m2) adults, aged 20-55 y. We examined 4 serum inflammatory biomarkers: C-reactive protein (CRP), interleukin 6, and soluble tumor necrosis factor receptors I and II; a urinary inflammation biomarker: prostaglandin E2-metabolite; and a urinary oxidative stress biomarker: F2-isoprostane. Plasma proteomics on an antibody array was performed to explore other pathways modulated by glucosamine and chondroitin.<h4>Results</h4>Serum CRP concentrations were 23% lower after glucosamine and chondroitin compared to placebo (P = 0.048). There were no significant differences in other biomarkers. In the proteomics analyses, several pathways were significantly different between the interventions after Bonferroni correction, the most significant being a reduction in the "cytokine activity" pathway (P = 2.6 x 10-16), after glucosamine and chondroitin compared to placebo.<h4>Conclusion</h4>Glucosamine and chondroitin supplementation may lower systemic inflammation and alter other pathways in healthy, overweight individuals. This study adds evidence for potential mechanisms supporting epidemiologic findings that glucosamine and chondroitin are associated with reduced risk of lung and colorectal cancer.<h4>Trial registration</h4>ClinicalTrials.gov NCT01682694. |
| format | Article |
| id | doaj-art-e2a3a47582824ef6a39cce6871418cb9 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-e2a3a47582824ef6a39cce6871418cb92025-08-20T02:15:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01102e011753410.1371/journal.pone.0117534Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans.Sandi L NavarroEmily WhiteElizabeth D KantorYuzheng ZhangJunghyun RhoXiaoling SongGinger L MilnePaul D LampeJohanna W Lampe<h4>Background</h4>Glucosamine and chondroitin are popular non-vitamin dietary supplements used for osteoarthritis. Long-term use is associated with lower incidence of colorectal and lung cancers and with lower mortality; however, the mechanism underlying these observations is unknown. In vitro and animal studies show that glucosamine and chondroitin inhibit NF-kB, a central mediator of inflammation, but no definitive trials have been done in healthy humans.<h4>Methods</h4>We conducted a randomized, double-blind, placebo-controlled, cross-over study to assess the effects of glucosamine hydrochloride (1500 mg/d) plus chondroitin sulfate (1200 mg/d) for 28 days compared to placebo in 18 (9 men, 9 women) healthy, overweight (body mass index 25.0-32.5 kg/m2) adults, aged 20-55 y. We examined 4 serum inflammatory biomarkers: C-reactive protein (CRP), interleukin 6, and soluble tumor necrosis factor receptors I and II; a urinary inflammation biomarker: prostaglandin E2-metabolite; and a urinary oxidative stress biomarker: F2-isoprostane. Plasma proteomics on an antibody array was performed to explore other pathways modulated by glucosamine and chondroitin.<h4>Results</h4>Serum CRP concentrations were 23% lower after glucosamine and chondroitin compared to placebo (P = 0.048). There were no significant differences in other biomarkers. In the proteomics analyses, several pathways were significantly different between the interventions after Bonferroni correction, the most significant being a reduction in the "cytokine activity" pathway (P = 2.6 x 10-16), after glucosamine and chondroitin compared to placebo.<h4>Conclusion</h4>Glucosamine and chondroitin supplementation may lower systemic inflammation and alter other pathways in healthy, overweight individuals. This study adds evidence for potential mechanisms supporting epidemiologic findings that glucosamine and chondroitin are associated with reduced risk of lung and colorectal cancer.<h4>Trial registration</h4>ClinicalTrials.gov NCT01682694.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117534&type=printable |
| spellingShingle | Sandi L Navarro Emily White Elizabeth D Kantor Yuzheng Zhang Junghyun Rho Xiaoling Song Ginger L Milne Paul D Lampe Johanna W Lampe Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. PLoS ONE |
| title | Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. |
| title_full | Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. |
| title_fullStr | Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. |
| title_full_unstemmed | Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. |
| title_short | Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans. |
| title_sort | randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humans |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117534&type=printable |
| work_keys_str_mv | AT sandilnavarro randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans AT emilywhite randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans AT elizabethdkantor randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans AT yuzhengzhang randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans AT junghyunrho randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans AT xiaolingsong randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans AT gingerlmilne randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans AT pauldlampe randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans AT johannawlampe randomizedtrialofglucosamineandchondroitinsupplementationoninflammationandoxidativestressbiomarkersandplasmaproteomicsprofilesinhealthyhumans |